Cancer inactivating BRCA2 mutations are characterized by large tandem duplications and deletions (67) which are typical for RAD52-mediated BIR and SSA repair mechanisms, contributing to rearrangements, fuelling genomic instability and oncogenic transformation (24,68). This evidence concerns the gene RAD52 and cancer.